TAK-593 N-(5-((2-(环丙烷甲酰胺基)咪唑并[1,2-b]哒嗪-6-基)氧基)-2-甲基苯基)-1,3-二甲基-1H-吡唑-5-甲酰胺
CAS 1005780-62-0 MFCD105780620
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- TAK-593 is a n oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation.